https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9975751/
Czarnowska A, Kapica-Topczewska K, Tarasów E, Tarasiuk J, Chorąży M, Kochanowicz J, Kułakowska A. Case report: First manifestation of multiple sclerosis temporally correlated with COVID-19...
Announcement
Collapse
No announcement yet.
Search Result
Collapse
10 results in 0.0480 seconds.
Keywords
Members
Tags
-
Emily started a topic Front Neurol. - Case report: First manifestation of multiple sclerosis temporally correlated with COVID-19 vaccinationin VaccinesFront Neurol. - Case report: First manifestation of multiple sclerosis temporally correlated with COVID-19 vaccination
-
tetano started a topic J Korean Med Sci . Sudden Death Associated With Possible Flare-Ups of Multiple Sclerosis After COVID-19 Vaccination and Infection: A Case Report and Literature Reviewin VaccinesJ Korean Med Sci . Sudden Death Associated With Possible Flare-Ups of Multiple Sclerosis After COVID-19 Vaccination and Infection: A Case Report and Literature Review
J Korean Med Sci
. 2023 Mar 13;38(10):e78.
doi: 10.3346/jkms.2023.38.e78.
Sudden Death Associated With Possible Flare-Ups of Multiple Sclerosis After COVID-19 Vaccination and Infection: A Case Report and Literature Re...
-
Gray Matter Is Targeted in First-Attack Multiple Sclerosis
-
Possible simple cure for multiple sclerosis
Researcher's labour of love leads to MS breakthrough
André Picard and Avis Favaro
From Saturday's Globe and Mail
Published Friday, Nov. 20 2009, 9:07 PM EST
Last updated Thursday, Aug. 23 2012, 12:21 PM EDT...
-
Vitamin D therapy may have helped fatigue symptoms in woman with progressive multiple sclerosis
http://www.yorkshirepost.co.uk/yorks...y-ms-1-5906211
(Tests showed she was very low in vitamin D prior to starting therapy.)...
-
Giuseppe started a topic The Lancet. Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trialin OtherThe Lancet. Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trial
[Source: The Lancet, full text: (LINK). Abstract, edited.]
The Lancet, Early Online Publication, 1 November 2012...
doi:10.1016/S0140-6736(12)61768-1
Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying
-
Giuseppe started a topic Arch Neurol. Yellow Fever Vaccination and Increased Relapse Rate in Travelers With Multiple Sclerosisin Yellow FeverArch Neurol. Yellow Fever Vaccination and Increased Relapse Rate in Travelers With Multiple Sclerosis
[Source: JAMA, Archive of Neurology, full text: (LINK). Abstract, edited.]ONLINE FIRST
...
Yellow Fever Vaccination and Increased Relapse Rate in Travelers With Multiple Sclerosis
Mauricio F. Farez, MD, MPH; Jorge
-
AlaskaDenise started a topic Good video of immune system action (MS, but applicable to other diseases)in ImmunityGood video of immune system action (MS, but applicable to other diseases)
This U-tube video is produced to promote a drug for multiple sclerosis, but it has a very good animation of how the applicable portion of the immune system works - t-cells, bytokines, etc., etc.
See:
http://www.youtube....
-
Giuseppe started a topic Arch Neurol. Clinical Effect of Neutralizing Antibodies to Interferon Beta That Persist Long After Cessation of Therapy for Multiple Sclerosisin OtherArch Neurol. Clinical Effect of Neutralizing Antibodies to Interferon Beta That Persist Long After Cessation of Therapy for Multiple Sclerosis
Clinical Effect of Neutralizing Antibodies to Interferon Beta That Persist Long After Cessation of Therapy for Multiple Sclerosis (Arch Neurol., abstract, edited)
Clinical Effect of Neutralizing Antibodies to Interferon Beta That Persist Long...